next-generation sequencing

Abterra Biosciences is enabling the next-generation of antibody therapeutics. Its technologies use next-generation sequencing, mass spectrometry, and machine learning methods to comprehensively map the antibody response to challenge. The company began as Digital Proteomics LLC, a spin-out of the University of California – San Diego, founded by professors Pavel Pevzner and Vineet Bafna.

antibody discoveryantibody sequencingB-cell receptor sequencingBioinformaticsmachine learningmass spectrometry

FREE TRIAL: Sequence Accuracy Showdown WPS + Sanger. Compare and Confirm.Send us one sample for Whole Plasmid Sequencing (WPS) and up to two primers for free Sanger sequencing confirmation. Receive a summary report comparing the data between the two technologies.Available for new and existing users. Sign In to Place Your Order New WPS Run Schedule 5 Days a Week! • Next Day TAT • Free Repeats Starting at $12 Sign In to Place Your Order Refer-a-Friend Program Receive 50% OFF on your next order - you and your referral. Sign-in to your account for more details.(Offer valid up to $200 off.) Sign In to your Account Campus Visits All visitors to our booths will receive a 50% discount on their next Whole Plasmid or Sanger sequencing order.(Offer valid up to $50 off.) View our Events Schedule ACGT is now in the San Francisco Bay Area ACGT has opened a new lab in the San Francisco Bay Area.

Bioinformaticscopy number analysisDirect Colony Sequencingfragment length analysisGLP/GMP compliant sequencingmetagenomicsprimer walkingSanger sequencingSNP genotypingWhole Plasmid Sequencing

Alacris Theranostics GmbH is a systems medicine company based in Berlin offering next-generation sequencing (NGS) and bioinformatics services for research, pharma, and precision medicine. It provides end-to-end NGS workflows from sample collection to data analysis, and operates an ISO 15189 medically accredited laboratory. Its Alacris-CMTA® platform delivers Deep Comprehensive Genomic Profiling for personalized cancer diagnostics.

bioinformatics analysisclinical NGS analysisgenomic and epigenomic analysisISO 15189 accredited laboratorymetagenomicsRNA-seqsingle-cell sequencingspatial transcriptomicstranscriptomic analysiswhole exome sequencingwhole genome bisulfite sequencingwhole genome sequencing

Atlas Biotech spun its mutational scanning technology out of Penn State in 2024. The company provides functional genomics services, including quantitative deep mutational scanning (qDMS) to measure dose-response and IC50 values for thousands of protein variants, custom cell line development, specificity screening (TELTALE), and functional genomics (Bypass) screens. Its work has centered on oncology, with applications in rare and inflammatory diseases.

cell line developmentDNA library generationdose-response analysisfunctional genomicsquantitative deep mutational scanningsaturation mutagenesisspecificity screening

Avrok Biosciences is an integrated specialty laboratory and contract research organization (CRO) that delivers complete biospecimen services under one roof, including procurement, processing, testing, bioinformatics, and biostorage. The company supports drug development, diagnostics, clinical studies, and translational research, and through its Beyond the Bench Initiative donates a portion of proceeds from every completed project to a nonprofit in the same therapeutic area.

ABO typingELISAGC/MS/MSHLA typingLC/MS/MSMicroarrayPBMC/plasma/serum isolationPCR and qPCRwhole exome sequencingwhole genome sequencing

Ayass Research Institute is a research organization committed to focused and efficient scientific innovations using advanced technologies. Its work spans transcriptome analysis, cervical cancer early detection, cancer metastasis research, aptamer development, spatial profiling, COVID-19 research, next-generation sequencing, and machine learning-based disease prediction. It also offers bioinformatics and iScan genotyping/methylation services.

aptamer developmentbioinformatics data analysiscustom panel designgenotyping arraysmachine learning disease predictionmethylation array analysisspatial profilingstatistical analysistranscriptome sequencing

Base Pair Biotechnologies, Inc. is an aptamer discovery and development company based in Pearland, TX. It provides custom aptamer discovery and development, multiplex SELEX, bioinformatics for aptamer selection, affinity determination, aptamer maturation, catalog aptamers and reagents, assay development, custom cell culture services, and isothermal titration calorimetry (ITC) binding services.

affinity testingaptamer maturationaptamer selectionassay developmentbacterial cell cultureBioinformaticsBLI affinity testingcell line engineeringisothermal titration calorimetry (ITC)mammalian cell cultureMSTmultiplex SELEXplasmid preparationrecombinant protein expression

Biocognon LLC is a Pittsburgh, PA startup co-founded in early 2023 by Carnegie Mellon University scientists Dr. Christopher Szent-Gyorgyi and Dr. Robert van de Weerd. It is developing a Nanobody discovery platform based on patented fluorogen activating proteins and a combinatorial yeast screening platform for discovery of Nanobodies for therapeutic and diagnostic antibodies.

Artificial IntelligenceBioinformaticscombinatorial yeast screeningmachine learningsynthetic biology

Biotia is a health tech company and spinout of the Jacobs Technion-Cornell Institute at Cornell Tech, advancing infectious disease diagnostics for challenging infections. It pairs clinical metagenomics and artificial intelligence to develop diagnostic and software solutions for patients, providers, and health systems, and operates a high complexity, CLIA-certified diagnostic laboratory in New York City.

Artificial IntelligenceCLIA-certified diagnostic laboratoryclinical metagenomicsgenomic surveillancepathogen genomics software

Biovac Nepal Private Limited is a vaccine research, development and manufacturing company based in Nepal. It specializes in field-based disease surveillance, molecular diagnostic and genomics-based disease detection, and vaccine target evaluation, stabilization and manufacturing. It partners with institutions on vaccine research and development, including the University of Queensland. It aims to produce disease-preventing poultry vaccines developed and manufactured in Nepal and to establish a vaccine production laboratory and manufacturing unit in Banepa

field-based disease surveillancegenomics-based disease detectionGIS and disease modelingMobile application developmentmolecular diagnosticsvaccine manufacturingvaccine research and development

BioVendor is a developer and manufacturer of research and diagnostic products, including immunoassays, recombinant proteins, antibodies, and endotoxin-removal products. Its products are the result of long-term biotechnology R&D activities aimed at the international research and diagnostic community, and its customers include world-renowned scientific institutions.

biotechnology R&Dimmunoassay developmentmonoclonal and polyclonal antibody developmentrecombinant protein production

BreakSight® Inc. spun out of research in Dr. Eric Brown's laboratory at the University of Pennsylvania, where Nishita Shastri developed the BrITL technique to tag and retrieve DNA double-strand break ends from the genome. The company provides commercial assays and services for genome-wide DNA break mapping, bioinformatics analysis, and precision medicine research, aiming to expand coverage to the non-coding 98% of the genome.

bioinformatics analysisDNA double-strand break mappinglibrary preparationpeak callingquality controlRNA-seq analysis

Bullseye Biosciences is a therapeutics discovery company that uses directed evolution inside living cells to discover functional molecules against challenging intracellular targets. Its platform combines in-cell directed evolution with automation and Next Generation Sequencing to enable scalable discovery, generating functionally annotated datasets. The company is progressing a lead program toward in vivo evaluation and is expanding into intracellular targets across oncology, immunology, and beyond.

automationin-cell directed evolutionintracellular selection systemsmolecular glue discoverymulti-protein complex stabilizationprotein interaction disruption

Cambridge Technologies, based in Worthington, Minnesota, is a custom vaccine company offering Precision Vaccinology®, a combination of next-generation diagnostics and quality custom manufacturing. It operates a full-service diagnostics laboratory featuring next-generation sequencing to identify viral and bacterial pathogens, and custom manufactures herd-specific autogenous vaccines for veterinarians. It is described as an industry leader in autogenous vaccines for beef and dairy cattle and also offers them for small ruminants.

autogenous vaccine formulationbacteriology culture and sensitivitycustom vaccine manufacturingmetagenomicsMLSTmultiplex PCRSCORE processSuperconcentrate formulationtoxin typingvirus isolation

Captis Diagnostics develops extracellular vesicle (EV) isolation technology for minimally invasive human disease research and clinical diagnostics. Its Lipid Nanoprobe (LNP) platform enables rapid, high-efficiency EV isolation from human biofluids in 15 minutes or less without ultracentrifugation, supporting DNA mutation detection, RNA sequencing, and proteomics from a single blood draw. The company also offers precision EV isolation kits for multi-omics discovery and proteomics workflows.

DNA mutation detectionepigenomic profilingextracellular vesicle isolationliquid biopsymagnetic separationproteomicsRNA sequencing

Caris Life Sciences is a precision oncology company that analyzes DNA, RNA and proteins across tissue and blood to provide molecular profiling for cancer patients. Its tests support early cancer detection, treatment selection, clinical trial matching and therapy development for physicians and biopharma partners.

Artificial Intelligencecirculating nucleic acid sequencingclinical trial matchingcomputational pathologymolecular profilingwhole exome sequencingwhole transcriptome sequencing

Center for Aquaculture Technologies (CAT) provides genetic services for the aquaculture industry, including genotyping, genomics, breeding programs, and genome editing. The company states it has experience working with the genomes of over 35 different aquatic species and offers an integrated Next-Gen Breeding strategy combining genome editing, genotyping, and selective breeding. CAT is part of the Cuna del Mar family.

Bioinformaticscustom array developmentdata analysisgenome assemblygenome editingmicrosatellite genotypingselective breedingSNP genotyping

CSIR-CCMB is a premier research organization in frontier areas of modern biology, based in Hyderabad, Telangana, India. It addresses fundamental questions in biology and develops technology from basic research findings toward unmet societal needs, creating novel solutions in medicine, agriculture and wildlife conservation.

Advanced Microscopy and Cell SortingAnimal Biosafety Level-3 LabAutomated DNA SequencingAutomated KaryotypingBioinformaticscell cultureDNA MicroarrayFlow CytometryIntegrative Structural BiologyproteomicsspectroscopyTransgenic FacilityZebrafish Laboratory

Cerba Research provides specialty and central lab solutions for clinical trials, backed by scientific expertise and a global network. It offers specialty lab testing, biomarker testing, and centralized lab management to sponsors worldwide, with a network of 42 laboratories across five continents and more than 50 years of scientific excellence.

Anatomic pathology and tissue analysisAssay development and technology transferbioanalysisBiospecimens logisticsCentralized lab managementDigital imaging and analysisDNA/RNA analysisFlow CytometryhistopathologyIHC and antibody servicesimmune repertoire sequencingimmunoassaysMultiplex and hybridization imagingPre-analytical and PBMCPreclinicalProtocol developmentRoutine and safety testingSample kit distributionspatial omics

ClickSeq Technologies LLC provides Next-Generation Sequencing services and kits based on its patented ClickSeq™ library preparation method, which uses Click-Chemistry in place of fragmentases and ligases. Offerings include RNAseq, DNAseq, Poly(A)-targeted and template-targeting sequencing, sequencing on Illumina platforms, and bioinformatics support and analysis.

bioinformatics analysiscustom primer designlibrary synthesissequencing on Illumina platforms

CorePath is a CLIA-certified and CAP-accredited laboratory headquartered in San Antonio, Texas, offering cancer diagnosis including morphologic evaluation, second opinion, immunohistochemistry, multicolor flow cytometry, cytogenetics, FISH, molecular genetics, next generation sequencing and liquid biopsy testing. Its team of Board Certified Pathologists and clinical lab scientists provides diagnosis for cancer patients in the United States and worldwide.

biomarkers analysisclinical trialscytogeneticsFISHhistologyimmunohistochemistryliquid biopsymulticolor flow cytometrynew test and platform validationtissue banking

Crown Biome Inc builds bioinformatic data infrastructure for optimizing AI within electronic health records. The company offers algorithmic correlation using next-generation sequencing of microbiome sampling for chronic illness detection, algorithmic nutritional recommendations based on an individual's microbiome, herbal and probiotic supplement customization, and API integration of electronic health records for data collection and referral network connectivity.

AI within electronic health recordsalgorithmic correlationAPI integration of electronic health recordsmicrobiome sampling

CuraPath Dx is a molecular diagnostics laboratory in Houston, TX, specializing in molecular testing for wound care and infectious diseases. It pairs high-complexity molecular diagnostics with general health testing such as CBCs and metabolic panels, and is CLIA-certified and COLA-accredited, with most results delivered within 36 hours.

high-complexity molecular assayslogistics and trackingmolecular testingpharmacogenomicsresults and reportingsample collection kits

Divergene is a technology company providing AI-driven analytics and informatics for cell & gene therapy and bioprocessing. It offers a bioinformatics platform and AI framework for next-generation sequencing analysis, vector engineering, and vector quality control, and provides AI-driven digital-twin simulation of bioreactors and bioprocesses. The team includes Ph.D.-level bioinformaticians, data scientists, and AI experts.

AI-driven digital-twin simulationBioinformaticsbioprocess modelingcapsid engineeringlibrary preparationQCsequencing analysisvector engineeringvector quality control